Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation.

Kwara A, Lartey M, Boamah I, Rezk NL, Oliver-Commey J, Kenu E, Kashuba AD, Court MH.

J Clin Pharmacol. 2009 Sep;49(9):1079-90. doi: 10.1177/0091270009338482. Epub 2009 Jul 23.

3.

Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.

Spooner KM, Lane HC, Masur H.

Clin Infect Dis. 1996 Jul;23(1):15-27. Review. No abstract available.

PMID:
8816123
4.

Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Bhana N, Ormrod D, Perry CM, Figgitt DP.

Paediatr Drugs. 2002;4(8):515-53. Review.

PMID:
12126455
5.

Clinical pharmacokinetics of stavudine.

Rana KZ, Dudley MN.

Clin Pharmacokinet. 1997 Oct;33(4):276-84. Review.

PMID:
9342503
6.

Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.

Shey MS, Kongnyuy EJ, Alobwede SM, Wiysonge CS.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD005481. doi: 10.1002/14651858.CD005481.pub3. Review.

PMID:
23543540
7.

Clinical pharmacokinetics of zidovudine. An overview of current data.

Collins JM, Unadkat JD.

Clin Pharmacokinet. 1989 Jul;17(1):1-9. Review. No abstract available.

PMID:
2663302

Supplemental Content

Support Center